Increasing levels of haemoglobin and CRP were significantly associated with lower disease control rates during chemotherapy, whereas haemostatic biomarkers (D-dimer, F1+2) predicted for a lower probability of disease control with borderline significance.
← all excerpts
Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer.
1
—
—